Kezar Life Sciences, Inc. (KZR)
6.29
+0.03
(+0.48%)
USD |
NASDAQ |
Dec 31, 16:00
6.26
-0.03
(-0.48%)
After-Hours: 20:00
Kezar Life Sciences Market Cap: 46.06M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Artiva Biotherapeutics, Inc. | 104.52M |
| NovaBay Pharmaceuticals, Inc. | 710.70M |
| Palatin Technologies, Inc. | 14.30M |
| Theriva Biologics, Inc. | 7.099M |
| Oragenics, Inc. | 0.6445M |
Market Cap Related Metrics
| Price to Book Value | 0.5551 |
| Price | 6.29 |
| Earnings Yield | -134.2% |